Abstract:Background The relationship between gut microbiota and in vivo coronary plaque characteristics has not been reported. This study was conducted to investigate the relationship between gut microbiota and coronary plaque characteristics in patients with coronary artery disease. Methods and Results Patients who underwent both optical coherence tomography and intravascular ultrasound imaging and provided stool and blood specimens were included. The composition of gut microbiota was evaluated using 16S rRNA sequencing. A total of 55 patients were included. At the genus level, 2 bacteria were associated with the presence of thin‐cap fibroatheroma, and 9 bacteria were associated with smaller fibrous cap thickness. Among them, some bacteria had significant associations with inflammatory/prothrombotic biomarkers. Dysgonomonas had a positive correlation with interleukin‐6, Paraprevotella had a positive correlation with fibrinogen and negative correlation with high‐density lipoprotein cholesterol, Succinatimonas had positive correlations with fibrinogen and homocysteine, and Bacillus had positive correlations with fibrinogen and high‐sensitivity C‐reactive protein. In addition, Paraprevotella , Succinatimonas , and Bacillus were also associated with greater plaque volume. Ten bacteria were associated with larger fibrous cap thickness. Some were associated with protective biomarker changes; Anaerostipes had negative correlations with trimethylamine N‐oxide, tumor necrosis factor α, and interleukin‐6, and Dielma had negative correlations with trimethylamine N‐oxide, white blood cells, plasminogen activator inhibitor‐1, and homocysteine, and a positive correlation with high‐density lipoprotein cholesterol. Conclusions Bacteria that were associated with vulnerable coronary plaque phenotype and greater plaque burden were identified. These bacteria were also associated with elevated inflammatory or prothrombotic biomarkers. Registration URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000041692. Nonstandard Abbreviations and Acronyms EEM external elastic membrane FCT fibrous cap thickness LDA linear discriminant analysis PAV percent atheroma volume PB plaque burden SAP stable angina pectoris SCFA short‐chain fatty acid TAV normalized normalized total atheroma volume TCFA thin‐cap fibroatheroma TMAO trimethylamine N‐oxide Clinical Perspective What Is New? In the current study, we investigated the detailed relationship between gut microbiota and coronary plaque characteristics using both optical coherence tomography and intravascular ultrasound. Bacteria associated with favorable and unfavorable plaque characteristics were identified. Some bacteria associated with vulnerable plaque features also had significant associations with inflammatory/prothrombotic biomarkers. What Are the Clinical Implications? Gut microbiota may play an important role in vulnerable plaque formation. Large‐scale studies with long‐term follow‐up are required to confirm the findings of this pilot study. Once the current findings are confirmed, the microbiome may be used not only for risk stratification but also for identification of potential therapeutic targets. Recently, the role of gut microbiota in various health conditions has been gaining attention. 1 , 2 , 3 Dysbiosis of gut microbiota and microbial metabolites, such as trimethylamine N‐oxide (TMAO) and short‐chain fatty acid, were reported to have strong associations with cardiovascular diseases such as atherosclerosis, heart failure, and hypertension. 1 <sup -Abstract Truncated-

Structural differences in bacterial lipopolysaccharides determine atherosclerotic plaque progression by regulating the accumulation of neutrophils

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis

Both gut microbiota and cytokines act to atherosclerosis in ApoE -/- mice

Endotoxinemia Accelerates Atherosclerosis Through Electrostatic Charge-Mediated Monocyte Adhesion

Cytokines and atherosclerosis: a comprehensive review of studies in mice

A possible beneficial effect of Bacteroides on faecal lipopolysaccharide activity and cardiovascular diseases

Neutrophils recruited by leukotriene B4 induce features of plaque destabilization during endotoxaemia

Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice

Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice

Transient increase in atherosclerotic plaque macrophage content following Streptococcus pneumoniae pneumonia in ApoE-deficient mice

Impact of Probiotic Lactiplantibacillus plantarum ATCC 14917 on atherosclerotic plaque and its mechanism

Staphylococcus aureus extracellular adherence protein (Eap) reduces immune cell phenotype in developing but not in established atherosclerotic lesions

Contrast enhanced ultrasound molecular imaging of platelets in the inflammatory procession of atherosclerosis

Abstract: P1122 EFFECTS OF MACROPHAGE ABCA7 DEFICIENCY ON LIPID METABOLISM AND THE DEVELOPMENT OF ATHEROSCLEROSIS IN LDL RECEPTOR KNOCKOUT MICE

Gut Microbiota and Coronary Plaque Characteristics.

Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis

Atherosclerosis: cell biology and lipoproteins--new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells.

Polymicrobial Oral Infection with Four Periodontal Bacteria Orchestrates a Distinct Inflammatory Response and Atherosclerosis in ApoE null Mice

Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation

Aminoadipic acid aggravates atherosclerotic vascular inflammation through ROS/TXNIP/NLRP3 pathway, a harmful microbial metabolite reduced by paeonol

Abstract TP300: Apolipoprotein-E Deficiency and High Fat Diet Alter Immunomodulatory Cellular and Molecular Determinants Promoting Atherosclerosis, a Stroke Risk Factor